The FDA Oncology Center of Excellence, in collaboration with theUCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) will hold a public workshop to explore clinical trial designs and innovations that will aid in ioptimizing outcomes in early breast cancer.
The workshop is scheduled for October 29, 2018 at the FDA White Oak Campus in Silver Spring, MD.
The objectives of the workshop are to:
The workshop will also be live streamed for those unable to attend in person.
Quantum Leap Healthcare Collaborative